In the most recent trading session, Hologic (HOLX) closed at $65.11, indicating a +1.31% shift from the previous trading day.
Backed by robust profitability, HOLX deploys billions into acquisitions and repurchases to boost future earnings.
As demand for GYN surgical tools climbs, HOLX and COO battle it out. Find out which stock shows stronger growth momentum now.
Medical - Instruments & Supplies Industry | Healthcare Sector | Mr. Stephen P. MacMillan CEO | XHAN Exchange | US4364401012 ISIN |
US Country | 7,063 Employees | - Last Dividend | 3 Apr 2008 Last Split | 21 Jun 1990 IPO Date |
Hologic, Inc. is a pioneering company focused on improving women’s health through early detection and treatment, leveraging advanced diagnostics, medical imaging systems, and surgical products. Founded in 1985 with its headquarters in Marlborough, Massachusetts, Hologic operates across four distinct segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its commitment to innovation and improving patient outcomes positions Hologic as a leader in the healthcare industry, ensuring it meets the diverse needs of healthcare providers and patients alike.